世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

レミケード・バイオシミラーの世界市場レポート 2023年以下1)タイプ別タイプ別:100mg/10ml、500mg/50ml2)適応疾患別:潰瘍性大腸炎、関節リウマチ、強直性脊椎炎、クローン病潰瘍性大腸炎、関節リウマチ、強直性脊椎炎、クローンズ病、乾癬性関節炎、プラーク乾癬3) 用途別:血液疾患;がん疾患対象疾患アッヴィ社; ノバルティス社; アムジェン社; ヴィアトリス社; テバ社


Remicade Biosimilar Global Market Report 2023Including: 1) By Type: 100mg/10ml; 500mg/50ml2) By Disease Indication: Ulcerative Colitis; Rheumatoid Arthritis; Ankylosing Spondylitis; Crohns Disease; Psoriatic Arthritis; Plaque Psoriasis3) By Application: Blood Disorders; Oncology DiseasesCovering: AbbVie Inc.; Novartis AG; Amgen Inc; Viatris Inc.; Teva Pharmaceutical Industries Ltd.

The Business Research Companyのレミケードバイオシミラーの世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。 このレポートは力強い... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
The Business Research Company (TBRC)
ザ・ビジネスリサーチカンパニー
2023年9月21日 US$5,000
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
175 英語

 

サマリー

The Business Research Companyのレミケードバイオシミラーの世界市場レポート2023は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。

このレポートは力強い成長を遂げているレミケードバイオシミラー市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドのガイドを提供します。

購入の理由
- 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真のグローバルな視点を得ることができます。
- 市場がCOVID-19の影響をどのように受けてきたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。
- ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。
- 世界的な高インフレが市場成長に与える影響を測定する。
- 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。
- 投資の対象となる成長セグメントを特定する。
- 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。
- 最新の市場シェアに基づいて顧客を理解する。
- 主要な競合他社に対する業績のベンチマーク
- 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。
- レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3~5営業日以内にお届けします。
- レポートの全データは、エクセルのダッシュボード形式でも納品されます。

説明
レミケード・バイオシミラーの市場が最も大きく、急成長しているのはどこか?経済全体、人口動態、他の類似市場との関連は?今後どのような力が市場を形成していくのか?ビジネスリサーチ社のレミケードバイオシミラー世界市場レポートがこれらすべての疑問やその他多くの疑問にお答えします。

当レポートでは、市場の特徴、規模および成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、トレンド、戦略を網羅しています。地域別に市場の過去および予測市場成長を追跡します。

調査範囲

対象市場:1) タイプ別100mg/10ml、500mg/50ml
2) 疾患別適応症適応疾患別:潰瘍性大腸炎、関節リウマチ、強直性脊椎炎、クローン病、関節症性乾癬、尋常性乾癬
3) 用途別血液疾患;腫瘍疾患

言及された企業アッヴィ社、ノバルティス社、アムジェン社、ヴィアトリス社、テバ・ファーマシューティカル・インダストリーズ社、アムジェン社、アムジェン社、アムジェン社、テバ・ファーマシューティカル・インダストリーズ社

国名オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン

地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ

時系列:過去5年間および過去10年間の予測。

データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、

データ区分:国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。

ソーシングと参照:本レポート中のデータおよび分析は、エンドノートを使用しています。

納品形式PDF、Word、Excel データダッシュボード。

ページTOPに戻る


目次

1. Executive Summary
2. Remicade Biosimilar Market Characteristics
3. Remicade Biosimilar Market Trends And Strategies
4. Remicade Biosimilar Market - Macro Economic Scenario
4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Remicade Biosimilar Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Remicade Biosimilar Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Remicade Biosimilar Market Drivers and Restraints
5.3.1. Drivers Of The Market
5.3.2. Restraints Of The Market
6. Remicade Biosimilar Market Segmentation
6.1. Global Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
100mg/10ml
500mg/50ml
6.2. Global Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Ulcerative Colitis
Rheumatoid Arthritis
Ankylosing Spondylitis
Crohn’s Disease
Psoriatic Arthritis
Plaque Psoriasis
6.3. Global Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Blood Disorders
Oncology Diseases
7. Remicade Biosimilar Market Regional And Country Analysis
7.1. Global Remicade Biosimilar Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Remicade Biosimilar Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Remicade Biosimilar Market
8.1. Asia-Pacific Remicade Biosimilar Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Remicade Biosimilar Market
9.1. China Remicade Biosimilar Market Overview
9.2. China Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Remicade Biosimilar Market
10.1. India Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Remicade Biosimilar Market
11.1. Japan Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Remicade Biosimilar Market
12.1. Australia Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Remicade Biosimilar Market
13.1. Indonesia Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Remicade Biosimilar Market
14.1. South Korea Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Remicade Biosimilar Market
15.1. Western Europe Remicade Biosimilar Market Overview
15.2. Western Europe Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Remicade Biosimilar Market
16.1. UK Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Remicade Biosimilar Market
17.1. Germany Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Remicade Biosimilar Market
18.1. France Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Italy Remicade Biosimilar Market
19.1. Italy Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Spain Remicade Biosimilar Market
20.1. Spain Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. Eastern Europe Remicade Biosimilar Market
21.1. Eastern Europe Remicade Biosimilar Market Overview
21.2. Eastern Europe Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. Russia Remicade Biosimilar Market
22.1. Russia Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. North America Remicade Biosimilar Market
23.1. North America Remicade Biosimilar Market Overview
23.2. North America Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. USA Remicade Biosimilar Market
24.1. USA Remicade Biosimilar Market Overview
24.2. USA Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Canada Remicade Biosimilar Market
25.1. Canada Remicade Biosimilar Market Overview
25.2. Canada Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. South America Remicade Biosimilar Market
26.1. South America Remicade Biosimilar Market Overview
26.2. South America Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Brazil Remicade Biosimilar Market
27.1. Brazil Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28. Middle East Remicade Biosimilar Market
28.1. Middle East Remicade Biosimilar Market Overview
28.2. Middle East Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29. Africa Remicade Biosimilar Market
29.1. Africa Remicade Biosimilar Market Overview
29.2. Africa Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
30. Remicade Biosimilar Market Competitive Landscape And Company Profiles
30.1. Remicade Biosimilar Market Competitive Landscape
30.2. Remicade Biosimilar Market Company Profiles
30.2.1. AbbVie Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Novartis AG
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Amgen Inc
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Viatris Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Teva Pharmaceutical Industries Ltd.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Remicade Biosimilar Market Other Major And Innovative Companies
31.1. Biogen Inc.
31.2. Organon & Co.
31.3. Merck And Co. Inc.
31.4. Janssen Biotech Inc.
31.5. LG Chem Ltd.
31.6. Nippon Kayaku Co. Ltd.
31.7. Celltrion Inc.
31.8. Nichi-iko Pharmaceutical Co. Ltd.
31.9. Biocon Limited
31.10. Alvogen Inc
31.11. Synthon International Holding B.V.
31.12. Coherus Biosciences Inc
31.13. Cardinal Health Inc
31.14. Genentech Inc.
31.15. Alvotech S.A.
32. Global Remicade Biosimilar Market Competitive Benchmarking
33. Global Remicade Biosimilar Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Remicade Biosimilar Market
35. Remicade Biosimilar Market Future Outlook and Potential Analysis
35.1 Remicade Biosimilar Market In 2027 - Countries Offering Most New Opportunities
35.2 Remicade Biosimilar Market In 2027 - Segments Offering Most New Opportunities
35.3 Remicade Biosimilar Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

 

ページTOPに戻る


 

Summary

Remicade Biosimilar Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on remicade biosimilar market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for remicade biosimilar? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The remicade biosimilar market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

Markets Covered:1) By Type: 100mg/10ml; 500mg/50ml
2) By Disease Indication: Ulcerative Colitis; Rheumatoid Arthritis; Ankylosing Spondylitis; Crohn’s Disease; Psoriatic Arthritis; Plaque Psoriasis
3) By Application: Blood Disorders; Oncology Diseases

Companies Mentioned: AbbVie Inc.; Novartis AG; Amgen Inc; Viatris Inc.; Teva Pharmaceutical Industries Ltd.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.



ページTOPに戻る


Table of Contents

1. Executive Summary
2. Remicade Biosimilar Market Characteristics
3. Remicade Biosimilar Market Trends And Strategies
4. Remicade Biosimilar Market - Macro Economic Scenario
4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Remicade Biosimilar Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Remicade Biosimilar Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Remicade Biosimilar Market Drivers and Restraints
5.3.1. Drivers Of The Market
5.3.2. Restraints Of The Market
6. Remicade Biosimilar Market Segmentation
6.1. Global Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
100mg/10ml
500mg/50ml
6.2. Global Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Ulcerative Colitis
Rheumatoid Arthritis
Ankylosing Spondylitis
Crohn’s Disease
Psoriatic Arthritis
Plaque Psoriasis
6.3. Global Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Blood Disorders
Oncology Diseases
7. Remicade Biosimilar Market Regional And Country Analysis
7.1. Global Remicade Biosimilar Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Remicade Biosimilar Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Remicade Biosimilar Market
8.1. Asia-Pacific Remicade Biosimilar Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Remicade Biosimilar Market
9.1. China Remicade Biosimilar Market Overview
9.2. China Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Remicade Biosimilar Market
10.1. India Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Remicade Biosimilar Market
11.1. Japan Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Remicade Biosimilar Market
12.1. Australia Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Remicade Biosimilar Market
13.1. Indonesia Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Remicade Biosimilar Market
14.1. South Korea Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Remicade Biosimilar Market
15.1. Western Europe Remicade Biosimilar Market Overview
15.2. Western Europe Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Remicade Biosimilar Market
16.1. UK Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Remicade Biosimilar Market
17.1. Germany Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Remicade Biosimilar Market
18.1. France Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Italy Remicade Biosimilar Market
19.1. Italy Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Spain Remicade Biosimilar Market
20.1. Spain Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. Eastern Europe Remicade Biosimilar Market
21.1. Eastern Europe Remicade Biosimilar Market Overview
21.2. Eastern Europe Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. Russia Remicade Biosimilar Market
22.1. Russia Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. North America Remicade Biosimilar Market
23.1. North America Remicade Biosimilar Market Overview
23.2. North America Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. USA Remicade Biosimilar Market
24.1. USA Remicade Biosimilar Market Overview
24.2. USA Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Canada Remicade Biosimilar Market
25.1. Canada Remicade Biosimilar Market Overview
25.2. Canada Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. South America Remicade Biosimilar Market
26.1. South America Remicade Biosimilar Market Overview
26.2. South America Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Brazil Remicade Biosimilar Market
27.1. Brazil Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28. Middle East Remicade Biosimilar Market
28.1. Middle East Remicade Biosimilar Market Overview
28.2. Middle East Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29. Africa Remicade Biosimilar Market
29.1. Africa Remicade Biosimilar Market Overview
29.2. Africa Remicade Biosimilar Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa Remicade Biosimilar Market, Segmentation By Disease Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa Remicade Biosimilar Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
30. Remicade Biosimilar Market Competitive Landscape And Company Profiles
30.1. Remicade Biosimilar Market Competitive Landscape
30.2. Remicade Biosimilar Market Company Profiles
30.2.1. AbbVie Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Novartis AG
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Amgen Inc
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Viatris Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Teva Pharmaceutical Industries Ltd.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Remicade Biosimilar Market Other Major And Innovative Companies
31.1. Biogen Inc.
31.2. Organon & Co.
31.3. Merck And Co. Inc.
31.4. Janssen Biotech Inc.
31.5. LG Chem Ltd.
31.6. Nippon Kayaku Co. Ltd.
31.7. Celltrion Inc.
31.8. Nichi-iko Pharmaceutical Co. Ltd.
31.9. Biocon Limited
31.10. Alvogen Inc
31.11. Synthon International Holding B.V.
31.12. Coherus Biosciences Inc
31.13. Cardinal Health Inc
31.14. Genentech Inc.
31.15. Alvotech S.A.
32. Global Remicade Biosimilar Market Competitive Benchmarking
33. Global Remicade Biosimilar Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Remicade Biosimilar Market
35. Remicade Biosimilar Market Future Outlook and Potential Analysis
35.1 Remicade Biosimilar Market In 2027 - Countries Offering Most New Opportunities
35.2 Remicade Biosimilar Market In 2027 - Segments Offering Most New Opportunities
35.3 Remicade Biosimilar Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

The Business Research Company (TBRC)社の医薬分野での最新刊レポート


よくあるご質問


The Business Research Company (TBRC)社はどのような調査会社ですか?


The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る